CPH Chemie + Papier Holding AG

SIX:CPHN.SW

67.8 (CHF) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CHF.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002
Revenue 623.982725.351496.693445.189524.657537.391473.123437.546420.278492.817481.85488.691520.932417.396481.674570.358593.523507.758462.561426.196409.111413.325
Cost of Revenue 499.364600.141499.616401.415447.577336.944330.818290.297305.062342.305354.211329.612342.82275.069278.187335.395289.976227.688227.022184.228175.329192.491
Gross Profit 124.618125.21-2.92343.77477.08200.447142.305147.249115.216150.512127.639159.079178.112142.327203.487234.963303.547280.07235.539241.968233.782220.834
Gross Profit Ratio 0.20.173-0.0060.0980.1470.3730.3010.3370.2740.3050.2650.3260.3420.3410.4220.4120.5110.5520.5090.5680.5710.534
Reseach & Development Expenses 0000000000000000000000
General & Administrative Expenses 000000017.5115.61417.84718.9299.64419.51716.5621.14923.1490.5110.612106.65799.834102.314100.38
Selling & Marketing Expenses 000000071.45970.71769.83166.70300000000000
SG&A 55.23733.75824.9324.73426.0892.337110.84488.96986.33187.67885.62399.64419.51716.5621.14923.1490.5110.612106.65799.834102.314100.38
Other Expenses 13.422-8.0211.040.6760.7442.4491.641-0.71.8091.4791.82433.92230.4113.31926.48117.98252.435227.8764.292.5419.3572.273
Operating Expenses 41.81533.75823.8924.05825.336150.003118.82146.467143.393134.016402.923181.313198.089172.987194.972202.812252.946228.488213.702203.524211.425209.44
Operating Income 82.80391.452-26.81319.71651.74451.6332.9015.891-21.81816.037-30.878-22.234-19.977-30.668.51540.56450.45548.8744.14729.12822.99328.568
Operating Income Ratio 0.1330.126-0.0540.0440.0990.0960.0060.013-0.0520.033-0.064-0.045-0.038-0.0730.0180.0710.0850.0960.0950.0680.0560.069
Total Other Income Expenses Net 9.1778.704-122.40219.1360.035-5.91616.236-9.33-10.292-4.142-248.738-2.468-29.943-5.038-3.036-3.0541.78112.4710.6684.626-16.231-4.49
Income Before Tax 91.98100.156-149.21538.85251.77945.71719.137-3.439-32.1111.895-279.6169.657-20.438-26.72336.89437.5152.23661.3454.81533.75427.0724.078
Income Before Tax Ratio 0.1470.138-0.30.0870.0990.0850.04-0.008-0.0760.024-0.580.02-0.039-0.0640.0770.0660.0880.1210.1190.0790.0660.058
Income Tax Expense 12.974-0.8862.195-8.1113.3263.4372.954.2751.0131.3938.1361.596-2.447-6.7131.1126.9149.25111.9319.8549.2245.657.142
Net Income 78.885100.953-151.55946.90148.34142.29315.983-7.905-33.12310.502-271.488.061-17.991-20.0135.78230.59643.37949.46444.96124.5321.4216.936
Net Income Ratio 0.1260.139-0.3050.1050.0920.0790.034-0.018-0.0790.021-0.5630.016-0.035-0.0480.0740.0540.0730.0970.0970.0580.0520.041
EPS 13.1516.83-25.267.828.067.052.66-1.32-5.521.75-45.251.34-3-3.354.855.27.258.247.54.053.552.8
EPS Diluted 13.1516.83-25.267.828.067.052.66-1.32-5.521.75-45.251.34-3-3.354.855.27.258.247.54.053.552.8
EBITDA 102.005110.0811.57250.20483.13882.05433.06536.4511.76550.27725.97972.46176.29737.833101.93399.395108.589108.451109.16487.72296.0199.51
EBITDA Ratio 0.1630.1520.0030.1130.1580.1530.070.0830.0280.1020.0540.1480.1460.0910.2120.1740.1830.2140.2360.2060.2350.241